D. Stinchcomb

发表

Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences.

V. Ambros, C. Mello, C. Mello, 1991, The EMBO journal.

Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.

C. Huang, D. Stinchcomb, R. Kinney, 2011, Vaccine.

CD8+ T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate.

D. Stinchcomb, C. Partidos, J. Osorio, 2015, The Journal of infectious diseases.

Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani

S. Reed, D. Stinchcomb, N. Van Hoeven, 2018, Front. Immunol..

Studies on the transposable element Ty1 of yeast. I. RNA homologous to Ty1. II. Recombination and expression of Ty1 and adjacent sequences.

R. W. Davis, R. Elder, D. Stinchcomb, 1981, Cold Spring Harbor symposia on quantitative biology.

A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone

D. Stinchcomb, J. Osorio, D. Wallace, 2016, Expert review of vaccines.

Development of a recombinant, chimeric tetravalent dengue vaccine candidate.

D. Stinchcomb, C. Partidos, J. Osorio, 2015, Vaccine.

Intralesional lipid-complexed cytokine/superantigen immunogene therapy for spontaneous canine tumors

D. Thamm, D. Stinchcomb, E. Macewen, 2003, Cancer Immunology, Immunotherapy.

A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika.

R. Coler, S. Reed, D. Stinchcomb, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Centromeric DNA from Saccharomyces cerevisiae.

R. W. Davis, D. Stinchcomb, C. Mann, 1982, Journal of molecular biology.

A physiological study of functional expression in Escherichia coli of the cloned yeast imidazoleglycerolphosphate dehydratase gene.

R. W. Davis, K. Struhl, D. Stinchcomb, 1980, Journal of molecular biology.

STRUCTURAL AND FUNCTIONAL ANALYSIS OF THE HIS3 GENE AND GALACTOSE INDUCIBLE SEQUENCES IN YEAST

Ronald W. Davis, K. Struhl, D. Stinchcomb, 1979 .

Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.

S. Weaver, M. Suresh, D. Stinchcomb, 2013, Vaccine.

Studies on the Transposable Element Tyl of Yeast I. RNA Homologous to Tyl

R. W. Davis, R. Elder, D. Stinchcomb, 1981 .

Immunization of dogs and cats with a DNA vaccine against rabies virus.

C. Tomlinson, D. Stinchcomb, J. Osorio, 1999, Vaccine.

Anti-gene therapy: the use of ribozymes to inhibit gene function.

D. Stinchcomb, L. Couture, 1996, Trends in genetics : TIG.

Eukaryotic DNA segments capable of autonomous replication in yeast.

R. W. Davis, E. Selker, D. Stinchcomb, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Toward the therapeutic editing of mutated RNA sequences.

D. Stinchcomb, T. Woolf, J. M. Chase, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism

E. Wang, S. Weaver, R. Gorchakov, 2011, PLoS pathogens.

Recombinant raccoon pox vaccine protects mice against lethal plague.

D. Stinchcomb, J. Osorio, T. Rocke, 2003, Vaccine.

Constraining the cell cycle: Regulating cell division and differentiation by gene therapy

D. Stinchcomb, 1995, Nature Medicine.

Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling.

S. Weaver, A. Powers, D. Stinchcomb, 2011, Vaccine.

Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine.

S. Weaver, A. Powers, D. Stinchcomb, 2012, Vaccine.

Raccoon Poxvirus as a Mucosal Vaccine Vector for Domestic Cats

D. Stinchcomb, J. Osorio, Kelley J Moss, 2003, Journal of drug targeting.

Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study.

D. Stinchcomb, R. Rupp, J. Osorio, 2015, Vaccine.

Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial.

C. Huang, D. Stinchcomb, A. A. Haller, 2015, The Journal of infectious diseases.

Sterile host yeasts (SHY): a eukaryotic system of biological containment for recombinant DNA experiments.

D. Botstein, R. W. Davis, K. Struhl, 1979, Gene.

Chikungunya virus and prospects for a vaccine

Scott C Weaver, Jill A. Livengood, S. Weaver, 2012, Expert review of vaccines.

An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages.

D. Stinchcomb, Subash Das, H. Dean, 2019, Vaccine.

Design, Synthesis, and Function of Therapeutic Hammerhead Ribozymes

N. Usman, D. Stinchcomb, 1996 .

Characterization of cytokine production by the metrial gland and granulated metrial gland cells.

D. Stinchcomb, M. Browne, B. Croy, 1991, Journal of reproductive immunology.

High-frequency transformation of yeast: autonomous replication of hybrid DNA molecules.

R. W. Davis, K. Struhl, D. Stinchcomb, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates

D. Relman, S. Popper, D. Stinchcomb, 2016, PLoS neglected tropical diseases.

Extrachromosomal DNA transformation of Caenorhabditis elegans

D. Hirsh, D. Stinchcomb, J. Shaw, 1985, Molecular and cellular biology.

Victor Ambros (1953-)

G. Ruvkun, V. Ambros, D. Stinchcomb, 2020 .

Isolation and characterisation of a yeast chromosomal replicator

R. W. Davis, K. Struhl, Ronald W. Davis, 1979, Nature.

Antibody directed against Bacillus subtilis rho factor purified by sodium dodecyl sulfate slab gel electrophoresis. Effect on transcription by RNA polymerase in crude extracts of vegetative and sporulating cells.

R. Tjian, R. Losick, D. Stinchcomb, 1975, The Journal of biological chemistry.

IMMUNIZATION OF BLACK-TAILED PRAIRIE DOG AGAINST PLAGUE THROUGH CONSUMPTION OF VACCINE-LADEN BAITS

D. Stinchcomb, J. Osorio, T. Rocke, 2008, Journal of wildlife diseases.

A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen

D. E. Parks, D. Clements, R. Coler, 2018, npj Vaccines.

Protection of Black-Tailed Prairie Dogs (Cynomys ludovicianus) against Plague after Voluntary Consumption of Baits Containing Recombinant Raccoon Poxvirus Vaccine

D. Stinchcomb, J. Osorio, T. Rocke, 2004, Infection and Immunity.

Limited infection upon human exposure to a recombinant raccoon pox vaccine vector.

F. J. Dein, D. Stinchcomb, J. Osorio, 2004, Vaccine.

Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice.

D. Stinchcomb, J. Osorio, T. Powell, 2010, Vaccine.

Safety and immunogenicity of INV21, an inactivated vaccine candidate for the prevention of hand, foot and mouth disease caused by enterovirus 71

D. Stinchcomb, P. Tambyah, G. Gordon, 2012 .

DNA SEQUENCES THAT ALLOW THE REPLICATION AND SEGREGATION OF YEAST CHROMOSOMES

Ronald W. Davis, E. Selker, D. Stinchcomb, 1981 .

Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.

J. D. Thompson, J. Thompson, D. Stinchcomb, 1995, Nucleic acids research.

Ribozymes in gene therapy

D. Stinchcomb, D. Macejak, L. Couture, 1995, Nature Network Boston.

Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNA.

A. Beaudry, T. Jarvis, N. Usman, 1996, RNA.

Modified Vaccinia Virus Ankara Encoding Influenza Virus Hemagglutinin Induces Heterosubtypic Immunity in Macaques

K. Broman, Y. Kawaoka, T. Friedrich, 2014, Journal of Virology.

Genetic and Phenotypic Characterization of Manufacturing Seeds for a Tetravalent Dengue Vaccine (DENVax)

Jill A. Livengood, C. Huang, A. Brault, 2013, PLoS neglected tropical diseases.

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study.

C. Huang, I. Velez, D. Stinchcomb, 2014, The Lancet. Infectious diseases.

Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study.

L. Shek, I. Velez, D. Stinchcomb, 2016, The Journal of infectious diseases.

Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques.

Jill A. Livengood, C. Huang, D. Stinchcomb, 2011, The American journal of tropical medicine and hygiene.

PAR-2 is asymmetrically distributed and promotes association of P granules and PAR-1 with the cortex in C. elegans embryos.

K. Kemphues, D. Stinchcomb, D. Levitan, 1996, Development.

Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines.

Jill A. Livengood, C. Huang, D. Stinchcomb, 2011, Vaccine.

Structure and Expression of the Collagen Genes of C. Elegans a

D. Hirsh, J. Kramer, D. Stinchcomb, 1985, Annals of the New York Academy of Sciences.

hemagglutinin induces heterosubtypic immunity in

K. Broman, Y. Kawaoka, T. Friedrich, 2014 .

Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice.

C. Huang, D. Stinchcomb, C. Partidos, 2012, Vaccine.

Craig C. Mello (1960

V. Ambros, K. Kemphues, C. Mello, 2017 .

Optimizing the Cell Efficacy of Synthetic Ribozymes

T. Jarvis, A. Karpeisky, N. Usman, 1996, The Journal of Biological Chemistry.

A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen

D. E. Parks, D. Clements, R. Coler, 2018, npj Vaccines.

Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.

Jeremy C. Jones, D. Stinchcomb, C. Partidos, 2013, Vaccine.

par-2, a gene required for blastomere asymmetry in Caenorhabditis elegans, encodes zinc-finger and ATP-binding motifs.

K. Kemphues, D. Stinchcomb, Dan T. Stinchcomb, 1994, Proceedings of the National Academy of Sciences of the United States of America.

High-frequency transformation of yeast: Autonomous replication of hybrid DNA molecules (recombinant DNA/cloning vector/yeast plasmid/eukaryotic genetics/minichromosome)

D. Stinchcomb, Kevin Struhl, Stewart Scherer, 2016 .

Preclinical Evaluation of a Live Attenuated Chikungunya Vaccine

Jill A. Livengood, S. Weaver, D. Stinchcomb, 2012 .